Burning Rock Biotech Limited provided revenue guidance for the year 2022. The company currently expect full year 2022 revenues to be approximately RMB 620 million (USD 97.3 million), implying a 22% growth over full year 2021.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7599 USD | +1.61% | -10.61% | -18.29% |
02/04 | Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Revenue $75.7M | MT |
02/04 | Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Loss $-0.90 | MT |
1st Jan change | Capi. | |
---|---|---|
-18.29% | 78.85M | |
-19.14% | 8.22B | |
+47.11% | 3.73B | |
-8.06% | 2.46B | |
-38.71% | 2.46B | |
-8.84% | 2.36B | |
-12.64% | 1.78B | |
-18.90% | 1.52B | |
-40.78% | 1.21B | |
+8.32% | 1.12B |
- Stock Market
- Equities
- BNR Stock
- News Burning Rock Biotech Limited
- Burning Rock Biotech Limited Provides Revenue Guidance for the Year 2022